Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery sector [7] Core Insights - The U.S. pet functional food industry is evolving from a focus on disease treatment to optimizing health, with functional food becoming a necessary choice for pet owners seeking precise nutrition [16][20] - The market for functional pet food is projected to reach approximately $12.1 billion by 2024, accounting for 27% of the overall pet food market, with a CAGR of 14.2% from 2019 to 2024, significantly outpacing the industry average [2][16] - High entry barriers and strong R&D capabilities are crucial for brand premium pricing, with companies that can meet stringent AAFCO standards and provide clinical validation enjoying higher market positions [3][17] Summary by Sections Industry Overview - The U.S. pet functional food market is not a legally defined category but an upgraded staple food that adds functional ingredients to balanced nutrition, evolving through stages from prescription food to functional food [2][20] - The shift towards functional food reflects a deeper understanding of pet health management, driven by consumer demand for precise feeding [16][20] Barriers to Entry - The industry has high entry barriers due to dual federal and state regulations, requiring compliance with AAFCO standards and rigorous nutritional validation [3][17] - Companies with strong R&D capabilities can command higher brand premiums, as seen in the price differences among similar products based on ingredient quality and efficacy validation [3][17] Market Structure - The functional food market is more fragmented compared to the prescription food market, where major players like Hill's and Royal Canin dominate with a combined market share of 90% [4][18] - The top three brands in the functional food segment hold only 57.1% of the market share, allowing for more competition from mid-tier brands [4][18] Investment Recommendations - The report suggests focusing on leading pet companies with strong R&D capabilities, such as Guai Bao Pet, Zhongchong Co., and Petty Co., as they are expected to benefit from the ongoing product iteration wave [6][10]